- Investing Ideas
- Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Shanghai Allist Pharmaceuticals
Market Cap: CN¥36.6b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥80.20
7D
-3.7%
1Y
-16.5%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥34.2b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥54.94
7D
-3.5%
1Y
-8.4%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥12.8b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥36.30
7D
-1.1%
1Y
-0.9%